60 likes | 70 Views
The global kidney cancer drugs market was valued at about $3.3 billion in 2018 and is expected to grow to $3.95 billion at a CAGR of 4.6% through 2022. Read more at http://bit.ly/2v5MZy6
E N D
Global Global Kidney Cancer Drugs Kidney Cancer Drugs Market | Global Industry Future Trends, Revenue Growth, and Leading Future Trends, Revenue Growth, and Leading Players 2020 2020- -2022 2022 Market | Global Industry Players Kidney Cancer Drugs Global Market Report 2020 © The Business Research Company. All rights reserved. www.tbrc.info Email: info@tbrc.info
• The kidney cancer drugs market consists of sales of kidney cancer drugs. It includes immunotherapy, chemotherapy and targeted therapy. • The global kidney cancer drugs market was valued at about $3.3 billion in 2018 and is expected to grow to $3.95 billion at a CAGR of 4.6% through 2022. • The regions covered are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Kidney Cancer Drugs Global Market Report 2020 2 © The Business Research Company. All rights reserved.
Chapters from Table of Content Chapter 1. Executive Summary Chapter 2. Kidney Cancer Drugs Market Characteristics Chapter 3. Kidney Cancer Drugs Market Size And Growth Chapter 4. Kidney Cancer Drugs Market Segmentation Chapter 5. Kidney Cancer Drugs Market Regional And Country Analysis ……. Chapter 27. Kidney Cancer Drugs Market Trends And Strategies Chapter 28. Product Pipeline Analysis Chapter 29. Kidney Cancer Drugs Market Future Outlook and Potential Analysis Chapter 30. Appendix 3
Companies Mentioned: Bayer AG, Pfizer Inc, Novartis International AG, Exelixis, Inc, F. Hoffmann-La Roche Ag. Segments: • By Type • By Geography Request a Sample copy of this report 4 © The Business Research Company. All rights reserved.
Few Points from List of Tables Table 1: Global Historic Market Growth, 2014-2018, $ Billion Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion Table 3: Global Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion ……….. Table 67: Novartis International AG Financial Performance Table 68: Exelixis Inc. Financial Performance Table 69: F. Hoffmann-La Roche Ag Financial Performance 5
Europe Asia Americas The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info Follow us on our social media and message us! 6 © The Business Research Company. All rights reserved.